UBRELVY (ubrogepant) Patient Assistance Program
Don’t let the high cost of brand oral CGRP receptor antagonist acute migraine therapy disrupt your treatment. We help eligible patients access Ubrelvy (ubrogepant) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Ubrelvy (ubrogepant) is FDA-approved for acute treatment of migraine with or without aura in adults. It is an oral CGRP receptor antagonist (gepant) — does not cause vasoconstriction (unlike triptans).
- Without assistance, Ubrelvy costs commonly run approximately $950–$1,200 per 10-tablet pack.
- Through AffordMyPrescriptions, qualifying patients can access Ubrelvy for a flat $69.95 per month.
- There is no generic Ubrelvy in the U.S. as of 2026. Other gepants: rimegepant (Nurtec ODT — acute AND preventive), zavegepant (Zavzpret — intranasal). For acute migraine, generic triptans (sumatriptan, eletriptan, rizatriptan, zolmitriptan, etc.) are dramatically cheaper if cardiovascular contraindications don't preclude.
What Is Ubrelvy Prescription Assistance Program?
Ubrelvy PAP for migraine patients.
Eligibility, neurology/primary care coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- Ubrelvy $950–$1,200/pack. PAP can help; generic triptans much cheaper alternative:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$1,150 | Save ~$1,080/mo |
| CVS Pharmacy | ~$1,200 | Save ~$1,130/mo |
| Walmart | ~$990 | Save ~$2,180/mo |
| Costco | ~$2,220.00 | Save ~$2,150/mo |
Kroger | ~$2,250.00 | Save ~$2,180/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Tivicay Prescription Program?
The Patient Assistance Program is free to apply for and provides Tivicay at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Tivicay:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $2,200–$2,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Tivicay assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Tivicay Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Tivicay:
Tivicay (dolutegravir, DTG) is a once-daily integrase strand transfer inhibitor (INSTI) used as a component of HIV-1 antiretroviral therapy. It must be combined with other antiretrovirals (NRTI backbone, or rilpivirine in the case of suppressed adults). Dolutegravir has a particularly high genetic barrier to resistance.
How Tivicay Works:
HIV-1 replication requires integrase — a viral enzyme that splices the HIV DNA copy into the host cell’s chromosomes. Without integration, HIV cannot establish persistent infection. INSTIs block this critical step.
Dolutegravir binds HIV integrase at the active site and prevents strand transfer — blocking integration of viral DNA into the host genome. Dolutegravir has a particularly high genetic barrier to resistance, meaning HIV needs to accumulate multiple mutations before becoming resistant — this makes dolutegravir-based regimens more forgiving of occasional missed doses than older HIV drugs.
Form and use:
Tivicay is taken by mouth once daily (or twice daily in patients with INSTI resistance). Available as 10, 25, and 50 mg tablets. Tivicay PD is a 5 mg dispersible tablet for pediatric dosing. Can be taken with or without food. Avoid taking with calcium, iron, magnesium, or aluminum supplements within 2 hours before or 6 hours after.
Generic availability:
There is no generic Tivicay in the U.S. as of 2026. Dolutegravir is also available in fixed-dose combinations: Dovato (DTG/3TC), Triumeq (DTG/ABC/3TC), and Juluca (DTG/RPV). The combination tablets simplify dosing for patients who are also taking other ARVs. HIV guidelines recommend INSTI-based regimens as first-line therapy.
Warnings:
Tivicay carries warnings for hypersensitivity reactions including DRESS (drug reaction with eosinophilia and systemic symptoms), hepatotoxicity (especially with HBV/HCV co-infection), depression/suicidality (rare), immune reconstitution syndrome, embryo-fetal toxicity (initial concern about neural tube defects from preliminary Botswana data, mostly reassured by larger subsequent studies), and weight gain (a class effect with INSTIs). Significant drug interactions occur with polyvalent cations, rifampin, rifabutin, certain antiepileptics, and St. John’s wort.
FAQ (Frequently Asked Questions)
Cost?
$950–$1,200/pack. PAP at no cost; advocacy $69.95/month. Generic triptans much cheaper if not contraindicated.
Triptan or gepant?
For patients without cardiovascular contraindications, generic triptans are first-line (dramatically cheaper, similar efficacy). For patients with CAD, stroke history, peripheral vascular disease, or uncontrolled hypertension, gepants are preferred (no vasoconstriction).
Ubrelvy vs Nurtec ODT?
Both are oral gepants. Ubrelvy approved for acute migraine only. Nurtec ODT approved for both acute AND preventive — versatile if you need both functions.
Drug interactions?
Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, ritonavir) contraindicated. Moderate inhibitors (fluconazole, diltiazem, erythromycin, verapamil) require dose adjustment. Tell prescriber about all medications.
Pregnancy?
Limited safety data. Discuss with neurologist.
Denied?
Generic triptan if not contraindicated. NHF or Migraine Foundation may help.
Take Control of Your Medication Costs
If struggling with Ubrelvy cost, we can help — or consider generic triptan first-line. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.